Matches in SemOpenAlex for { <https://semopenalex.org/work/W4306181859> ?p ?o ?g. }
- W4306181859 endingPage "116282" @default.
- W4306181859 startingPage "116282" @default.
- W4306181859 abstract "The association between schizophrenia and nicotine addiction becomes evident during adolescence. Here, to investigate interactive events that might underlie the early establishment of this comorbidity, we used phencyclidine-evoked locomotor sensitization, a proxy model of psychotic behavior, and nicotine minipump infusions in adolescent mice. Considering the involvement of dopamine D2 receptors in both schizophrenia and addiction, we further tested their role by exposing mice to raclopride. Adolescent mice that were either exposed to nicotine (24 mg/Kg/day) or not, received single daily raclopride (0.5 mg/kg, s.c.) or saline followed by phencyclidine injections (10 mg/Kg, s.c.) during open field testing for 6 consecutive days (Acquisition phase, ACQ). Phencyclidine and nicotine challenges (Sensitization Test, ST) were carried out after a 5-day withdrawal. Ambulation escalated in response to repeated phencyclidine exposure during ACQ and was increased after phencyclidine challenge, evidencing development and expression of locomotor sensitization. Raclopride prevented phencyclidine-evoked development of sensitization. However, raclopride pre-exposure during ACQ only shortened its expression in phencyclidine-challenged mice. Nicotine failed to interfere with phencyclidine stimulatory effects during ACQ but potentiated raclopride inhibition during the first ACQ days. During ST, nicotine history shortened the expression of phencyclidine-evoked sensitization. Nicotine challenge had no impact on locomotion, which is consistent with a lack of nicotine/phencyclidine cross-sensitization. In conclusion, our results show that nicotine does not worsen, and may even ameliorate phencyclidine-sensitized psychotic-like behavior in adolescent mice. The potentiation of raclopride-mediated inhibition further suggests that nicotine transiently improves the therapeutic efficacy of medication on psychotic symptoms through mechanisms that converge on D2 receptors." @default.
- W4306181859 created "2022-10-14" @default.
- W4306181859 creator A5000188357 @default.
- W4306181859 creator A5012836363 @default.
- W4306181859 creator A5026058990 @default.
- W4306181859 creator A5050654958 @default.
- W4306181859 creator A5055069993 @default.
- W4306181859 creator A5055165197 @default.
- W4306181859 creator A5072420490 @default.
- W4306181859 creator A5090898187 @default.
- W4306181859 date "2022-12-01" @default.
- W4306181859 modified "2023-10-03" @default.
- W4306181859 title "Adolescent nicotine potentiates the inhibitory effect of raclopride, a D2R antagonist, on phencyclidine-sensitized psychotic-like behavior in mice" @default.
- W4306181859 cites W1490681631 @default.
- W4306181859 cites W176330000 @default.
- W4306181859 cites W1880990246 @default.
- W4306181859 cites W1908845545 @default.
- W4306181859 cites W1970672659 @default.
- W4306181859 cites W1972815121 @default.
- W4306181859 cites W1973141868 @default.
- W4306181859 cites W1975610252 @default.
- W4306181859 cites W1980862554 @default.
- W4306181859 cites W1990043440 @default.
- W4306181859 cites W1994921025 @default.
- W4306181859 cites W2008808029 @default.
- W4306181859 cites W2021489201 @default.
- W4306181859 cites W2028334241 @default.
- W4306181859 cites W2030395147 @default.
- W4306181859 cites W2034367323 @default.
- W4306181859 cites W2036557906 @default.
- W4306181859 cites W2036712141 @default.
- W4306181859 cites W2042886270 @default.
- W4306181859 cites W2044600697 @default.
- W4306181859 cites W2048312942 @default.
- W4306181859 cites W2048601608 @default.
- W4306181859 cites W2053209019 @default.
- W4306181859 cites W2054789315 @default.
- W4306181859 cites W2055186048 @default.
- W4306181859 cites W2056227380 @default.
- W4306181859 cites W2061747140 @default.
- W4306181859 cites W2070589644 @default.
- W4306181859 cites W2079147262 @default.
- W4306181859 cites W2084148205 @default.
- W4306181859 cites W2088956467 @default.
- W4306181859 cites W2091224498 @default.
- W4306181859 cites W2094492844 @default.
- W4306181859 cites W2099989397 @default.
- W4306181859 cites W2100210143 @default.
- W4306181859 cites W2108909652 @default.
- W4306181859 cites W2109825510 @default.
- W4306181859 cites W2113070351 @default.
- W4306181859 cites W2113742168 @default.
- W4306181859 cites W2114226702 @default.
- W4306181859 cites W2115872169 @default.
- W4306181859 cites W2123997849 @default.
- W4306181859 cites W2126866313 @default.
- W4306181859 cites W2138867080 @default.
- W4306181859 cites W2147583708 @default.
- W4306181859 cites W2156035025 @default.
- W4306181859 cites W2160829173 @default.
- W4306181859 cites W2162105640 @default.
- W4306181859 cites W2163324649 @default.
- W4306181859 cites W2163868009 @default.
- W4306181859 cites W2165209294 @default.
- W4306181859 cites W2172769838 @default.
- W4306181859 cites W2253069334 @default.
- W4306181859 cites W2332330514 @default.
- W4306181859 cites W2336924596 @default.
- W4306181859 cites W2338096289 @default.
- W4306181859 cites W2604420042 @default.
- W4306181859 cites W2605406130 @default.
- W4306181859 cites W2622315493 @default.
- W4306181859 cites W2756162648 @default.
- W4306181859 cites W2767863900 @default.
- W4306181859 cites W276958651 @default.
- W4306181859 cites W2802046728 @default.
- W4306181859 cites W2886835547 @default.
- W4306181859 cites W2891867293 @default.
- W4306181859 cites W2900868902 @default.
- W4306181859 cites W2903818578 @default.
- W4306181859 cites W2938741386 @default.
- W4306181859 cites W2944363708 @default.
- W4306181859 cites W2945807399 @default.
- W4306181859 cites W2978784026 @default.
- W4306181859 cites W2979867821 @default.
- W4306181859 cites W2980456921 @default.
- W4306181859 cites W2982340372 @default.
- W4306181859 cites W3081230052 @default.
- W4306181859 cites W3119193917 @default.
- W4306181859 cites W3142818671 @default.
- W4306181859 cites W3201305916 @default.
- W4306181859 cites W3204574281 @default.
- W4306181859 cites W4206666881 @default.
- W4306181859 cites W4211174138 @default.
- W4306181859 cites W614316023 @default.
- W4306181859 doi "https://doi.org/10.1016/j.taap.2022.116282" @default.
- W4306181859 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36252887" @default.
- W4306181859 hasPublicationYear "2022" @default.